Sepiapterin treatment in atherosclerosis.
Tarpey
Margaret M
MM
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology; D001708:Biopterins / Q000031:analogs & derivatives* / Q000172:deficiency / Q000378:metabolism; D006801:Humans; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III; D011621:Pteridines / Q000378:metabolism / Q000627:therapeutic use*; D011622:Pterins
D011621:Pteridines; D011622:Pterins; D001708:Biopterins; C016727:sepiapterin; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; C003402:sapropterin